Back to AMERIPRISE FINANCIAL INC AMERIPRISE FINANCIAL INC

EIGREIGR
15 quarters

Position history for AMERIPRISE FINANCIAL INCAMERIPRISE FINANCIAL INC's holdings in EIGER BIOPHARMACEUTICALS INC

AMERIPRISE FINANCIAL INC previously held 0 shares of EIGR (EIGER BIOPHARMACEUTICALS INC), worth $0 as of 2024-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$11.3M

Total Shares Change

-1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2023-Q4
Decreased
7.5M
-12.7%
$1.7M0.0%—
0
2023-Q3
Unchanged
8.6M
0.0%
$2.6M0.0%—
0
2023-Q2
Increased
8.6M
+7.0%
$6M0.0%—
29
2023-Q1
Increased
8M
+47.4%
$7.2M0.0%—
37
2022-Q4
Decreased
5.4M
-32.6%
$6.4M0.0%—
0
2022-Q3
Increased
8.1M
+5.2%
$60.8M0.0%—
31
2022-Q2
Increased
7.7M
+2.4%
$48.4M0.0%—
30
2022-Q1
Increased
7.5M
+6.4%
$62.2M0.0%—
31
2021-Q4
Increased
7M
+19.2%
$36.6M0.0%—
34
2021-Q3
Increased
5.9M
+7.2%
$39.5M0.0%—
31
2021-Q2
Increased
5.5M
+23.9%
$47M0.0%—
36
2021-Q1
Increased
4.5M
+13.5%
$39.4M0.0%—
33
2020-Q4
Increased
3.9M
+181.7%
$48.2M0.0%—
47
2020-Q3
New
1.4M
-
$11.3M0.0%—
39

Other major holders of EIGR: BNP PARIBAS FINANCIAL MARKETS, RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used